Is Sabra Healthcare Stock a Good Investment?
Sabra Healthcare Investment Advice | SBRA |
- Examine Sabra Healthcare's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Sabra Healthcare's leadership team and their track record. Good management can help Sabra Healthcare navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Diversified REITs space and any emerging trends that could impact Sabra Healthcare's business and its evolving consumer preferences.
- Compare Sabra Healthcare's performance and market position to its competitors. Analyze how Sabra Healthcare is positioned in terms of product offerings, innovation, and market share.
- Check if Sabra Healthcare pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Sabra Healthcare's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Sabra Healthcare REIT stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Sabra Healthcare REIT is a good investment.
Sell | Buy |
Strong Sell
Market Performance | OK | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Sabra Healthcare Stock
Researching Sabra Healthcare's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.6. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sabra Healthcare REIT last dividend was issued on the 15th of November 2024. The entity had 1:3 split on the 16th of November 2010.
To determine if Sabra Healthcare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Sabra Healthcare's research are outlined below:
| Sabra Healthcare REIT currently holds 2.45 B in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Sabra Healthcare REIT has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Sabra Healthcare's use of debt, we should always consider it together with its cash and equity. | |
| Sabra Healthcare has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of Sabra Healthcare shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Disposition of 2291 shares by Jessica Flores of Sabra Healthcare at 13.99 subject to Rule 16b-3 |
Sabra Healthcare Quarterly Cash And Short Term Investments |
|
Sabra Healthcare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Sabra Healthcare REIT. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Sabra Healthcare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Sabra Healthcare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Sabra Healthcare's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-08-07 | 2023-06-30 | 0.1 | 0.09 | -0.01 | 10 | ||
2011-11-02 | 2011-09-30 | 0.08 | 0.07 | -0.01 | 12 | ||
2011-08-02 | 2011-06-30 | 0.09 | 0.08 | -0.01 | 11 | ||
2020-11-05 | 2020-09-30 | 0.16 | 0.18 | 0.02 | 12 | ||
2011-05-04 | 2011-03-31 | 0.07 | 0.05 | -0.02 | 28 | ||
2024-10-31 | 2024-09-30 | 0.16 | 0.13 | -0.03 | 18 | ||
2024-05-08 | 2024-03-31 | 0.14 | 0.11 | -0.03 | 21 | ||
2020-05-06 | 2020-03-31 | 0.21 | 0.17 | -0.04 | 19 |
Know Sabra Healthcare's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Sabra Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sabra Healthcare REIT backward and forwards among themselves. Sabra Healthcare's institutional investor refers to the entity that pools money to purchase Sabra Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 3.4 M | Deutsche Bank Ag | 2024-06-30 | 3.3 M | Northern Trust Corp | 2024-09-30 | 3.3 M | Jpmorgan Chase & Co | 2024-06-30 | 3.1 M | Norges Bank | 2024-06-30 | 2.8 M | Apg Investments Us Inc | 2024-06-30 | 2.6 M | Systematic Financial Management Lp | 2024-09-30 | 2.3 M | Duff & Phelps Inv Mgmt Co (il) | 2024-06-30 | 2 M | Advisors Capital Management, Llc | 2024-09-30 | 1.9 M | Vanguard Group Inc | 2024-09-30 | 34.9 M | Blackrock Inc | 2024-06-30 | 34.4 M |
Sabra Healthcare's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.46 B.Market Cap |
|
Sabra Healthcare's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Capital Employed | 0.04 | 0.05 |
Determining Sabra Healthcare's profitability involves analyzing its financial statements and using various financial metrics to determine if Sabra Healthcare is a good buy. For example, gross profit margin measures Sabra Healthcare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Sabra Healthcare's profitability and make more informed investment decisions.
Please note, the presentation of Sabra Healthcare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sabra Healthcare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sabra Healthcare's management manipulating its earnings.
Evaluate Sabra Healthcare's management efficiency
Sabra Healthcare REIT has return on total asset (ROA) of 0.0283 % which means that it generated a profit of $0.0283 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0346 %, meaning that it created $0.0346 on every $100 dollars invested by stockholders. Sabra Healthcare's management efficiency ratios could be used to measure how well Sabra Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 0.05, whereas Return On Tangible Assets are forecasted to decline to 0. At present, Sabra Healthcare's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 387.9 M, whereas Total Assets are forecasted to decline to about 4.2 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 12.12 | 12.46 | |
| Tangible Book Value Per Share | 11.99 | 12.22 | |
| Enterprise Value Over EBITDA | 18.30 | 29.83 | |
| Price Book Value Ratio | 1.18 | 1.53 | |
| Enterprise Value Multiple | 18.30 | 29.83 | |
| Price Fair Value | 1.18 | 1.53 | |
| Enterprise Value | 5.7 B | 3.2 B |
The strategic initiatives led by Sabra Healthcare's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Dividend Yield 0.0648 | Forward Dividend Yield 0.0648 | Forward Dividend Rate 1.2 | Beta 1.235 |
Basic technical analysis of Sabra Stock
As of the 28th of November, Sabra Healthcare has the Risk Adjusted Performance of 0.1196, semi deviation of 1.56, and Coefficient Of Variation of 668.07. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sabra Healthcare REIT, as well as the relationship between them.Sabra Healthcare's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sabra Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sabra Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sabra Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sabra Healthcare's Outstanding Corporate Bonds
Sabra Healthcare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sabra Healthcare REIT uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sabra bonds can be classified according to their maturity, which is the date when Sabra Healthcare REIT has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| SBRA 32 01 DEC 31 Corp BondUS78574MAA18 | View | |
| US78572XAG60 Corp BondUS78572XAG60 | View | |
| SABHLD 1125 15 DEC 27 Corp BondUS78573NAH52 | View |
Understand Sabra Healthcare's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Sabra Healthcare's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1196 | |||
| Market Risk Adjusted Performance | (2.16) | |||
| Mean Deviation | 1.2 | |||
| Semi Deviation | 1.56 | |||
| Downside Deviation | 1.8 | |||
| Coefficient Of Variation | 668.07 | |||
| Standard Deviation | 1.57 | |||
| Variance | 2.48 | |||
| Information Ratio | 0.0668 | |||
| Jensen Alpha | 0.2382 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0583 | |||
| Treynor Ratio | (2.17) | |||
| Maximum Drawdown | 8.78 | |||
| Value At Risk | (2.50) | |||
| Potential Upside | 2.51 | |||
| Downside Variance | 3.25 | |||
| Semi Variance | 2.43 | |||
| Expected Short fall | (1.19) | |||
| Skewness | (0.48) | |||
| Kurtosis | 1.09 |
| Risk Adjusted Performance | 0.1196 | |||
| Market Risk Adjusted Performance | (2.16) | |||
| Mean Deviation | 1.2 | |||
| Semi Deviation | 1.56 | |||
| Downside Deviation | 1.8 | |||
| Coefficient Of Variation | 668.07 | |||
| Standard Deviation | 1.57 | |||
| Variance | 2.48 | |||
| Information Ratio | 0.0668 | |||
| Jensen Alpha | 0.2382 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0583 | |||
| Treynor Ratio | (2.17) | |||
| Maximum Drawdown | 8.78 | |||
| Value At Risk | (2.50) | |||
| Potential Upside | 2.51 | |||
| Downside Variance | 3.25 | |||
| Semi Variance | 2.43 | |||
| Expected Short fall | (1.19) | |||
| Skewness | (0.48) | |||
| Kurtosis | 1.09 |
Consider Sabra Healthcare's intraday indicators
Sabra Healthcare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sabra Healthcare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Sabra Healthcare Corporate Filings
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 18th of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 19th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 26th of April 2024 Other Reports | ViewVerify |
Sabra Stock media impact
Far too much social signal, news, headlines, and media speculation about Sabra Healthcare that are available to investors today. That information is available publicly through Sabra media outlets and privately through word of mouth or via Sabra internal channels. However, regardless of the origin, that massive amount of Sabra data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Sabra Healthcare news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Sabra Healthcare relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Sabra Healthcare's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Sabra Healthcare alpha.
Sabra Healthcare Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Sabra Healthcare can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Sabra Healthcare Corporate Management
| Jessica Flores | Chief VP | Profile | |
| Peter Nyland | Executive Management | Profile | |
| Michael Costa | CFO VP | Profile | |
| Eliza Gozar | Senior Investments | Profile | |
| Darrin Smith | Executive Investments | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.111 | Dividend Share 1.2 | Earnings Share 0.41 | Revenue Per Share 2.943 | Quarterly Revenue Growth 0.107 |
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Sabra Healthcare's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.